| Pharmaceutical Information |
| Drug Name |
Oxaprozin |
| Drug ID |
BADD_D01635 |
| Description |
Oxaprozin is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID), used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis. |
| Indications and Usage |
Used to relieve the inflammation, swelling, stiffness, and joint pain associated with rheumatoid arthritis and osteoarthritis. |
| Marketing Status |
approved |
| ATC Code |
M01AE12 |
| DrugBank ID |
DB00991
|
| KEGG ID |
D00463
|
| MeSH ID |
D000077431
|
| PubChem ID |
4614
|
| TTD Drug ID |
D0M9DC
|
| NDC Product Code |
60760-092; 63629-8724; 17349-0008; 59762-6002; 0025-1381; 60760-203; 63629-1345; 69238-1120; 61919-178; 61919-673; 71335-0617; 71335-0902; 62135-176; 55111-013; 55111-170; 60760-382; 0185-0141; 55289-601 |
| UNII |
MHJ80W9LRB
|
| Synonyms |
Oxaprozin | 4,5-Diphenyl-2-oxazolepropionic Acid | 4,5 Diphenyl 2 oxazolepropionic Acid | Wy-21,743 | Wy 21,743 | Daypro | Rhoxal-oxaprozin | Rhoxal oxaprozin | Apo-Oxaprozin | Apo Oxaprozin | Danoprox | Dayrun |
|
| Chemical Information |
| Molecular Formula |
C18H15NO3 |
| CAS Registry Number |
21256-18-8 |
| SMILES |
C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
